Fludeoxyglucose F 18 Injection Market Revenue was valued at USD 1.5 Billion in 2024 and is estimated to reach USD 2.8 Billion by 2033, growing at a CAGR of 7.5% from 2026 to 2033.
The Fludeoxyglucose F 18 Injection market in South Korea has witnessed significant growth due to its vital role in medical imaging, particularly in positron emission tomography (PET) scans. This radioactive glucose analogue, commonly used in oncology, neurology, and cardiology, provides detailed images of the body’s metabolic activity, assisting in diagnosing and monitoring diseases like cancer, Alzheimer’s, and heart disease.
Fludeoxyglucose F 18 Injection is typically manufactured by specialized pharmaceutical companies that adhere to strict regulatory standards set by the Korean Ministry of Food and Drug Safety (MFDS). Its primary market requirement comes from hospitals and medical research institutions, which rely heavily on its ability to detect abnormalities at the cellular level. The need for high-quality PET imaging agents is driven by advancements in medical technology, as well as increasing awareness of the importance of early diagnosis.
As the demand for accurate diagnostic tools grows, South Korea’s healthcare sector is placing a heightened focus on acquiring high-grade Fludeoxyglucose F 18 Injection for both routine scans and experimental purposes. This is reflected in the rising number of PET scanning centers throughout the country. These centers, both public and private, are essential in ensuring that patients have access to timely and effective diagnostic solutions.
Another key industry driving the need for Fludeoxyglucose F 18 Injection is the growing field of clinical research. South Korean institutions and pharmaceutical companies invest heavily in developing new treatments and therapies, particularly for complex conditions like cancer. The injection’s role in preclinical and clinical trials is indispensable, helping researchers understand how various drugs or therapies impact cellular activity and disease progression.
In addition, the increasing prevalence of diseases such as cancer and neurological disorders is contributing to the rising demand for PET scans, which in turn boosts the requirement for Fludeoxyglucose F 18 Injection. Hospitals are expanding their diagnostic capabilities, while private institutions are seeking to improve their diagnostic accuracy, further intensifying the demand for this essential imaging agent.
As the Fludeoxyglucose F 18 Injection market continues to expand, South Korea remains a crucial player in the global medical imaging field, with its robust healthcare infrastructure and strong research orientation. The future of the market looks promising, as both the pharmaceutical and healthcare sectors are poised for continued growth and innovation in the use of Fludeoxyglucose F 18 Injection.
Get an In-Depth Research Analysis of the South Korea Fludeoxyglucose F 18 Injection Market Size And Forecast [2025-2032]
Isologic
Siemens(PETNet)
Yantai Dongcheng Biochemicals Co.
Ltd.
Hta Co.
Ltd
Guangdong Cyclotron Medical Science Co.
Ltd
HUAYI Technology
Shanghai Atom Kexing Pharmaceutical Co.
Ltd.
China Isotope & Radiation Corporation
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Fludeoxyglucose F 18 Injection Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Fludeoxyglucose F 18 Injection Market
Fludeoxyglucose F-18 Injection (Single-Dose)
Fludeoxyglucose F-18 Injection (Multi-Dose)
Fludeoxyglucose F-18 Injection (Pre-filled Syringes)
Oncology Diagnostics
Cardiology Imaging
Neurology Imaging
Infectious Disease Imaging
Metabolic Disorders Imaging
Hospitals
Diagnostic Imaging Centers
Research Institutions
Pharmaceutical Companies
Direct Sales
Distributors
Online Pharmacies
Refrigerated Storage
Room Temperature Storage
Controlled Environment Storage
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Fludeoxyglucose F 18 Injection Market Research Analysis
1. Introduction of the South Korea Fludeoxyglucose F 18 Injection Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Fludeoxyglucose F 18 Injection Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Fludeoxyglucose F 18 Injection Market, By Type
6. South Korea Fludeoxyglucose F 18 Injection Market, By Application
7. South Korea Fludeoxyglucose F 18 Injection Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Fludeoxyglucose F 18 Injection Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/